Broadcom stock surges 6.8% premarket toward a record after Q4 results late Thursday
6:53 am ET December 10, 2021 (MarketWatch) Print
(END) Dow Jones Newswires
December 10, 2021 06:53 ET (11:53 GMT)
Copyright (c) 2021 Dow Jones & Company, Inc.
enVVeno Medical CorpChange company Symbol lookupSelect an option...NVNO enVVeno Medical CorpMTBC CareCloud IncWRK Westrock CoSNDX Syndax Pharmaceuticals IncSLAMU Slam CorpSURYY Sumitomo Realty & Development Co LtdMKKGY Merck KGaADAC Danaos CorpYY JOYY IncMGU Macquarie Global Infrastructure Total Return Fund Inc.Go
Change company Symbol lookup
Select an option...
NVNO enVVeno Medical Corp
MTBC CareCloud Inc
WRK Westrock Co
SNDX Syndax Pharmaceuticals Inc
SLAMU Slam Corp
SURYY Sumitomo Realty & Development Co Ltd
MKKGY Merck KGaA
DAC Danaos Corp
YY JOYY Inc
MGU Macquarie Global Infrastructure Total Return Fund Inc.
Health Care : Health Care Equipment & Supplies | Small Cap Growth
Company profileenVVeno Medical Corporation is a med-tech company. The Company is focused on improving the standard of care in the treatment of venous disease. The Company is focused on developing tissue-based solutions that are designed for patients with chronic venous insufficiency (CVI). Its lead product, VenoValve, is a porcine based device being developed to surgically implanted in the deep venous system of the leg to treat severe CVI, including the potential to heal recurring venous leg ulcers. The VenoValve is designed to be implanted into the femoral vein of the patient in an open surgical procedure via a five-to-six-inch incision in the upper thigh. The VenoValve is being evaluated in the surgical anti-reflux venous valve endoprosthesis (SAVVE) United States clinical trial. In addition to the VenoValve, the Company is focused on the development of a second device, enVVe, for the treatment of venous disease.
|
|
|
|
| |
Earnings Calendar and Events Data provided by |Terms of Use| © 2022 Wall Street Horizon, Inc.
Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.
Options are not suitable for all investors as the special risks inherent to options trading may
expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.
Information and news provided by ,, , Computrade Systems, Inc., ,, and
Copyright © 2022. All rights reserved.